Health Canada medical device cybersecurity guidance raises PKI stakes

At a glance

What this is: Health Canada’s guidance is a pre-market cybersecurity framework for medical devices, with a key focus on secure authentication, encryption, access controls, and testing before release.

Why it matters: It matters because device identity, certificate handling, and lifecycle controls now sit inside regulated product design, which affects both NHI governance and broader IAM oversight in healthcare.

👉 Read DigiCert's guidance on Health Canada medical device cybersecurity

Context

Medical device cybersecurity is the discipline of securing connected clinical and consumer devices before and after they enter clinical use. In this guidance context, the key governance problem is that device identity and access are no longer confined to hospital networks. They extend into manufacturing, deployment, backend integration, and ongoing monitoring, which means security has to be designed into the product lifecycle rather than bolted on later.

Health Canada’s pre-market guidance reflects a broader shift in healthcare security: connected devices are now part of the identity plane. For practitioners, that means certificates, device authentication, backend trust, and access boundaries are governance issues as much as engineering tasks. The article treats the guidance as a welcome step because it makes security integral to product development, which is still not typical across the device market.

Key questions

Q: How should healthcare teams govern connected medical device identity?

A: Treat connected medical devices as managed identities with their own lifecycle. Each device should have a unique trust record, controlled authentication method, and revocation path. Governance must cover manufacturing, deployment, backend access, patching, and retirement, because the risk does not end when the device leaves the factory.

Q: Why do connected medical devices need PKI instead of shared credentials?

A: PKI gives each device a verifiable, revocable identity that backend systems can trust without relying on shared secrets. Shared credentials are hard to rotate safely across large fleets and make it difficult to isolate compromised devices. Certificates are stronger when tied to clear issuance and retirement controls.

Q: What breaks when medical device security is only checked after release?

A: Post-release checks miss the point where trust is first established. If authentication, encryption, and access boundaries are not designed in early, devices may ship with weak backend connections or unreviewed privileges. In regulated healthcare, that creates privacy, safety, and liability exposure that is expensive to unwind.

Q: Who is accountable for medical device cybersecurity in healthcare?

A: Accountability is shared across device manufacturers, regulators, healthcare IT, and operational users, but manufacturers carry the responsibility to build security into the product. Hospitals and clinicians still need controls for deployment, access, and monitoring. Effective governance assigns ownership across the full device lifecycle.

Technical breakdown

Secure device authentication to backend systems

Connected medical devices need a verifiable identity when they talk to servers, EHR systems, and other infrastructure. The article points to PKI and digital certificates as the strongest model because they bind device trust to cryptographic proof, not shared secrets or ad hoc configuration. That matters when devices move across networks, hospitals, and consumer environments. Authentication is only useful if it is tied to a managed certificate lifecycle and to trust decisions that can be revoked when device integrity changes.

Practical implication: treat certificate issuance, renewal, and revocation as part of device onboarding and offboarding, not as an afterthought.

Encryption and access controls for clinical device data

The guidance calls for securing connections and protecting data at rest and on device, which addresses two separate risks. First, transport exposure between devices and backend systems can reveal sensitive clinical data. Second, unmanaged access rights can let unauthorized users alter device settings or access telemetry. In healthcare, those failures can affect both privacy and patient safety. Access control for medical devices must therefore be specific to device function, operator role, and clinical context, not generic network access.

Practical implication: map device privileges to role and function, then enforce encryption and access boundaries at each point where data leaves the device.

Verification, validation, and monitoring as lifecycle controls

The article emphasises secure design, device-specific risk management, verification and validation, and monitoring for emerging risks. That sequence matters because medical device risk is not static. New integrations, firmware updates, and exposure in live environments can change the threat model after release. Security testing therefore has to be embedded into the manufacturer’s development and validation process, with monitoring used to catch regressions or new attack paths once devices are deployed.

Practical implication: make cybersecurity testing part of design verification and include post-market monitoring triggers for configuration and firmware drift.

NHI Mgmt Group analysis

Pre-market security is the only viable control point for medical device identity. Once a device is deployed into clinical or consumer use, the trust boundary becomes distributed across hospitals, networks, patients, and backend systems. That means secure identity, encryption, and access control have to be established before release, not discovered after incident response begins. For practitioners, the implication is that product security and identity governance are inseparable in regulated healthcare environments.

PKI is the most defensible identity model for connected devices because it replaces shared trust with managed cryptographic trust. The article’s emphasis on digital certificates reflects a real governance requirement: devices need distinct, revocable identities that can be verified by backend systems. Shared credentials and static configuration do not scale across medical device fleets. Practitioners should treat certificate lifecycle control as part of device governance, not just infrastructure administration.

Secure device design is a lifecycle problem, not a single control. Health Canada’s guidance ties together risk assessment, verification and validation, and monitoring because device behaviour changes over time. That is the same failure pattern seen in broader NHI programmes: identity is introduced at build time but governance is weakest at update, deployment, and retirement. The practical conclusion is that medical device programmes need continuous lifecycle control, not one-time certification.

Connected healthcare devices expose a governance gap between engineering ownership and security accountability. Manufacturers are expected to build security into devices, but hospitals and patients inherit the operational risk. That split makes offboarding, configuration control, and backend access governance essential. The implication is that device identity must be jointly governed across product, security, and clinical operations teams.

Medical device cybersecurity shows why identity control must extend beyond human access management. The article is about machines interacting with machines, but the governance lesson reaches human IAM as well: privilege, authentication, and trust have to be defined for every actor that can influence the device. Practitioners should align device identity, backend access, and operational access reviews under one governance model.

From our research:

• 1.5 out of 10 organisations are highly confident in their ability to secure NHIs, compared to nearly 1 in 4 for securing human identities, according to The State of Non-Human Identity Security.
• 85% of organisations lack full visibility into third-party vendors connected via OAuth apps, with 38% reporting no or low visibility and 47% reporting only partial visibility.
• For practitioners: use Top 10 NHI Issues to translate this visibility gap into a device and workload identity review programme before new clinical integrations expand the risk.

What this signals

Medical device programmes increasingly sit in the same governance category as other non-human identity estates: unique trust relationships, lifecycle control, and revocation discipline matter more than perimeter assumptions. The gap is not simply technical. It is organisational, because product engineering, security, and operations all influence whether device identity stays trustworthy after deployment.

Device trust debt: when healthcare organisations defer identity lifecycle controls until after shipment, they accumulate operational risk that becomes visible only during incident response. That pattern is familiar across NHI estates, where unmanaged certificates and stale access pathways persist long after the original deployment decision.

The practical signal for security teams is to unify device identity reviews with broader identity governance work. If your IAM or IGA programme does not already model backend trust, certificate ownership, and device retirement, it is missing a category of access that directly affects patient safety and regulatory exposure.

For practitioners

• Inventory every device-to-backend trust relationship Map each connected medical device to the servers, EHR systems, tablets, and cloud services it can reach. Record the authentication method, certificate owner, renewal process, and revocation path so that trust is visible before deployment.
• Bind device identity to PKI lifecycle controls Issue unique certificates per device class or instance, then define renewal, rotation, revocation, and retirement procedures alongside product release and field service workflows. Shared credentials create avoidable ambiguity when a device is relocated or replaced.
• Embed security testing into verification and validation Add device-specific abuse cases to validation plans, including unauthorised configuration changes, backend authentication failures, and data exposure in transit. Re-test when firmware, integrations, or cloud endpoints change.
• Extend monitoring into post-market device behaviour Track unusual authentication attempts, configuration drift, and unexpected data flows after release. Use those signals to trigger incident response and, when needed, device recall or certificate revocation.

Key takeaways

• Health Canada’s guidance moves medical device cybersecurity into the product lifecycle, where authentication, encryption, and access controls must be designed before release.
• Connected devices need managed identity and certificate lifecycle control because static trust models do not scale across hospitals, consumers, and backend systems.
• The strongest control improvement is to combine design-time testing with post-market monitoring so device trust can be validated, revoked, and governed continuously.

Key terms

• Medical Device Identity: The cryptographic and operational identity assigned to a device so backend systems can trust it as a distinct actor. In healthcare, this identity should be unique, revocable, and tied to lifecycle controls such as issuance, rotation, retirement, and validation.
• Device Lifecycle Governance: The control framework that manages a connected device from design through deployment, maintenance, and retirement. It includes authentication, configuration control, testing, monitoring, and revocation so risk does not accumulate after the device leaves the factory.
• PKI For Devices: A public key infrastructure model used to authenticate machines with certificates rather than shared secrets. For medical devices, PKI supports stronger trust in backend communications because identities are unique and can be revoked when the device or its environment changes.
• Pre-market Cybersecurity: Security work performed before a product is released into production or clinical use. In medical devices, it covers secure design, validation, encryption, and access control so the manufacturer can reduce risk before operational exposure begins.

Deepen your knowledge

NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are responsible for identity security strategy or NHI governance in your organisation, it is worth exploring.

This post draws on content published by DigiCert: Health Canada Guidance for Medical Device Cybersecurity is a Welcome Development. Read the original.